Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK "agrees to double" adult ECMO capacity in the face of H1N1 threat

This article was originally published in Clinica

Executive Summary

The UK's only provider of adult extracorporeal membrane oxygenation (ECMO) therapy is in discussions with the government over plans by the latter to "double the number of ECMO facilities". Clinica has learnt that an agreement among "all four UK health ministers" to this effect is still "subject to discussions", but the news is a clear acknowledgement of recent evidence of the crucial role that this technology can play in managing the most severe cases of H1N1 infection.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044399

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel